| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 13/01/2011 | 18:00 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES DELISTING FROM THE NASDAQ STOCK MARKET AND TRANSFER TO OTCQB™ MARKETPLACE | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 12/01/2011 | 21:00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreem | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 06/01/2011 | 23:26 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 06/01/2011 | 02:00 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES NOTICE OF DELISTING FROM THE NASDAQ STOCK MARKET | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 22/12/2010 | 20:30 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement to Extend Cure Period Under Subordinated Note Indenture | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 02/12/2010 | 18:18 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Preliminary Injunction Ruling In Connection With Rex Medical L.P. Litigation | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 29/11/2010 | 18:30 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES PRIVATE LABEL PRODUCT SUPPLY AGREEMENT WITH HOLOGIC | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 24/11/2010 | 20:15 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Commencement of Proceedings by Rex Medical LP | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 16/11/2010 | 23:08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 09/11/2010 | 11:00 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2010 | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 30/10/2010 | 02:00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 30/10/2010 | 02:00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces a Strongly Supported Transaction Agreement with Majority of Senior Subordinated Noteho | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 14/10/2010 | 01:00 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES CONFERENCE CALL AND WEBCAST | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 06/10/2010 | 14:00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against t | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 01/10/2010 | 14:00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Defers Interest Payments Under Senior Subordinated Notes. Angiotech Conducting Discussions With | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 24/09/2010 | 17:30 | PR Newswire (US) | ANGIOTECH ANNOUNCES THAT COOK MEDICAL'S ZILVER(R) PTX(R) DRUG-ELUTING STENT MEETS ITS PRIMARY ENDPOINT IN A 479-PATIENT, MULTI-C | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 23/09/2010 | 20:30 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS AND PARTNER ATHERSYS ANNOUNCE UPDATED RESULTS FROM PHASE I STUDY OF MULTISTEM(R) IN HEART ATTACK PATIE | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 22/09/2010 | 20:45 | PR Newswire (US) | ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION'S PLATINUM CHROMIUM TAXUS(R) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 22/09/2010 | 20:45 | PR Newswire (US) | ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGES FOR TAXUS(R) LIBERTÉ(R) STENT IN SMALL VESSELS AND LONG LESIONS | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 09/08/2010 | 22:40 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 09/08/2010 | 22:31 | Dow Jones News | UPDATE:FDA Warns About Long-Term Problems With Blood-Clot Device | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 09/08/2010 | 21:22 | Dow Jones News | FDA Warns About Long-Term Problems With Blood-Clot Device | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 30/07/2010 | 14:00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 28/07/2010 | 22:23 | PR Newswire (US) | Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack pati | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 08/07/2010 | 19:00 | PR Newswire (US) | Angiotech Pharmaceuticals announces notice of failure to satisfy a continued listing rule with The Nasdaq Stock Market. | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 24/06/2010 | 19:00 | PR Newswire (US) | Angiotech Pharmaceuticals Announces Conference Call and Webcast | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 16/06/2010 | 12:03 | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 11/06/2010 | 19:00 | PR Newswire (US) | Angiotech's licensee, Cook Medical, files PMA submission for FDA approval of Zilver(R) PTX(R) Drug-Eluting Stent platform | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 11/06/2010 | 00:30 | PR Newswire (US) | Angiotech Pharmaceuticals announces acceptance of 2010 medical design excellence award for Quill(TM) SRS | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
| 10/06/2010 | 20:00 | PR Newswire (US) | Angiotech Pharmaceuticals announces European launch and first implants of Boston Scientific Corporation's platinum chromium TAXU | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |